Introduction {#sec1-1}
============

Ischemic stroke, a high-risk disease with high mortality rate, is characterized by slow recovery and high incidence of disability, which seriously harms quality of life. Ischemic stroke accounts for 60--80% of strokes (Tan et al., 2011; Wang and Zeng, 2011). Cerebral ischemia/reperfusion injury triggers a characteristic signaling cascade (Ma et al., 2015). A previous study has shown that early intervention with acupuncture is a good secondary preventing injury after stroke (Niu, 2011). A clinical investigation of 102 patients showed that the best effects of acupuncture were between 12 hours and 1 week after stroke (Mao, 2011). Our laboratory has conducted animal experiments to investigate acute and chronic stroke combined with hyperlipidemia, and we have shown that electroacupuncture has remarkable effects during the very-early stage of stroke (Jin et al., 2003; Ma et al., 2006; Zhang et al., 2006). These findings indicate that stroke treatment has a rigid time window, and its long-term curative effect is therefore not always clear.

Release of adrenocorticotrophic hormone (ACTH) from the pituitary gland is a key signal that precedes the body\'s stress response. A strong stress response occurs in the acute phase of cerebral ischemia. Once the hypothalamus-pituitary-adrenal axis is activated, the anterior and intermediate lobes of pituitary gland secrete ACTH, which triggers the release of adrenocortical hormone, thus playing a role in the macro regulation of bodily functions (Rizzi et al., 2006). Heat shock protein 70 (Hsp70) is a protein involved in the stress response, and is the most conservative and dominant type of HSP family. Hsp70 is an antioxidant that acts to block apoptosis, can improve the plasticity of neurons, and is involved in neurotropic effects that are mediated by brain-derived neurotrophic factor (Malinverni et al., 2017; Zhang et al., 2017). Hsp70 is an endogenic danger signal that is synthesized when stress occurs in a cell, with expression levels being related to the degree of injury. Once synthesized, it starts a signaling cascade that leads to macrophage activation, and ultimately an innate immune response (Calderwood et al., 2007). Hsp70 can thus help maintain immunological homeostasis of proteins and regulate inflammation (Zheng et al., 2008; Kourtis et al., 2012). Additionally, its expression levels reflect changes in the state of an injury (Yu et al., 2013; Liu et al., 2015b; Zhang et al., 2016).

In this study, we used Sprague-Dawley rats to generate a model of ischemia using Zea Longa\'s method, and measured changing levels of ACTH and Hsp70 in the peripheral blood and brain tissue at different time points during the course of the stress-injury-repair sequence of events.

Materials and Methods {#sec1-2}
=====================

Experimental animals {#sec2-1}
--------------------

Clean and healthy 8-week-old male Sprague-Dawley rats (*n* = 130), weighing 275 ± 15 g, were provided by the Experimental Animal Resource Center, China\'s Food and Drug Verification Research Institute (license No. SCXK (Jing) 2009-0017). All rats were kept in the Grade II Animal Laboratory in the Institute of Basic Medical Sciences at the Chinese Academy of Medical Sciences. Rats were kept in separate cages for different groups, with 4--5 rats in each cage. The living environment was maintained at 25 ± 3°C, 75% relative humidity, and a 12/12-hour light/dark cycle. All rats were fed adaptively for 1 week with free access to food and water. The experiment strictly adhered to the Guide for Care and Use of Laboratory Animals, and the "3R" principle (Reduction, Replacement, and Refinement).

Rats were randomly divided into three groups: control (*n* = 10), middle cerebral artery occlusion (the MCAO group) (*n* = 60), and MCAO with electroacupuncture (the EA group) (*n* = 60). MCAO and EA groups were subdivided according to the following six time points: postoperative 12, 24, 48, 72, 96, and 144 hours (*n* = 10 each).

Establishment of the cerebral ischemia/reperfusion model {#sec2-2}
--------------------------------------------------------

Rat models were established by intraluminal cerebral ischemia and reperfusion (modified Zea Longa\'s method) (Longa et al., 1989). Each was placed on its back and fixed in place after intraperitoneal injection of 10% chloral hydrate (Sinophrm Chemical Reagent Co., Ltd., Shanghai, China; 0.35 mL/100 g) to induce anesthesia. The skin was incised approximately 2 cm at the center of the neck. Then, muscle and connective tissue were bluntly dissociated to expose the right common carotid artery, external carotid artery, and internal carotid artery. Excessive traction was avoided to prevent injury to the vagus nerve and blood vessels during the dissection. After ligating and cutting off the external carotid artery, an occlusion line (Beijing Sunbio Biotech Co., Ltd., Beijing, China) was inserted from the stump of the external carotid artery along the internal carotid artery approximately 18 ± 2 cm deep, and the reperfusion was conducted 2 hours after ischemia. The rats were allowed free access to food and water after waking up in their home cages. Neurological severity score was assessed using a modified Bederson\'s 5 grades point system (Wang et al., 2001) to confirm whether the model was successfully established. Rats with Grades 0 and 4 were excluded. In the control group, normal rats were used without any processing.

EA treatment {#sec2-3}
------------

MCAO rats were taken out of their cage once every day. EA rats were treated with EA at acupoints *Baihui* (DU20) and *Zusanli* (ST36) (bilateral) (acupuncture depth of 0.2 cm; acupuncture angle of 15°) with *Hua Tuo* sterile acupuncture needles (0.30 × 25 mm; Suzhou Medical Supplies Factory Co., Ltd., Suzhou, China). We used a dilatational wave delivered once a day for 20 minutes, with a frequency of 2--100 Hz and an amplitude of 2 mA. The first treatment was given 30 minutes after removal of the bolt, and the last treatment was given 150 minutes before euthanasia.

Neurological evaluation {#sec2-4}
-----------------------

At 12, 24, 48, 72, 96, and 144 hours after MCAO, we again assessed the neurological severity score: Grade 0: no dysfunction; Grade 1: foreleg cannot fully extend; Grade 2: flexion of the left foreleg, resistance decreases when animals were pushed to the left; Grade 3: rat veers to the left when crawling; Grade 4: rat loses consciousness, and may not survive another 24 hours.

2,3,5-Triphenyltetrazolium chloride (TTC) staining {#sec2-5}
--------------------------------------------------

Brain infarctions were observed using TTC staining 144 hours after MCAO. Rats were intraperitoneally anesthetized with 10% chloral hydrate (0.35 mL/100 g). Fresh brain tissue was put into a brain-section mold (East and West Instrument (Beijing) Technology, Beijing, China), cut with a surgical blade into 2 mm sections, then put in 0.1% TTC and incubated in a constant temperature box at 37°C for 30 minutes.

Hematoxylin-eosin staining {#sec2-6}
--------------------------

Morphological changes in the brain were observed *via* hematoxylin-eosin staining 144 hours after MCAO. After collection, brain tissue was rapidly frozen in the liquid nitrogen, and then placed at --80°C in a freezer. The frozen sections (2--3 mm in thickness) were placed in hematoxylin for 20 minutes, washed three times with water, treated with hydrochloric acid in alcohol for color separation, and followed by three washes with water. Subsequently, the sections were immersed in 0.5% ammonia. Nucleus staining was observed under a light microscope (Olympus (China) Company, Shanghai, China) until the nucleus turned blue. After three washes with water, sections were stained with eosin for 1 minute, washed 3--4 times, and dehydrated with 80% and 95% alcohol (once each), and 100% alcohol twice. Afterward, the sections were permeabilized twice with xylene, mounted with neutral balsam, and observed using a microscope (Olympus (China) Company).

Enzyme linked immunosorbent assay (ELISA) {#sec2-7}
-----------------------------------------

At 12, 24, 48, 72, 96, and 144 hours after MCAO, 6--7 mL of serum was taken from the left ventricle of the heart that was cut with scissors. The levels of ACTH and Hsp70 in the serum were measured by a commercially available ELISA kit for ACTH (Bachem, Bubendorf, Switzerland) and Hsp70 (EnzoLifeSciences, NY, USA) according to the manufacturer\'s instructions.

Statistical analysis {#sec2-8}
--------------------

Data were analyzed using SPSS 22.0 software (IBM Corp., Armonk, NY, USA). Normally distributed data of equal variances were compared across groups using one-way analysis of variance (ANOVA). Normally distributed data with unequal variances were compared with an approximate F test. Non-normally distributed data were compared with a non-parametric test. A value of *P* \< 0.05 was considered statistically significant. Data are expressed as the mean ± SD.

Results {#sec1-3}
=======

Loss of neurological function in MCAO rats {#sec2-9}
------------------------------------------

The control rats did not exhibit any neurological impairment, while those in the MCAO group exhibited different levels of neurologic impairment (**[Figure 1](#F1){ref-type="fig"}**). In the MCAO group, the neurological score tended to be lower for rats who lived longer. Compared with the newly modeled rats, highly significant differences in neurologic impairment were observed at 96 and 144 hours (all *P* \< 0.01; **[Table 1](#T1){ref-type="table"}**).

![Body torsion of cerebral ischemia/reperfusion rats.\
Unilateral damage leads to body twisting to the unaffected side.](NRR-12-925-g002){#F1}
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Neurological score of rats after model establishment and before execution

![](NRR-12-925-g003)

Pathological changes in MCAO rats {#sec2-10}
---------------------------------

### TTC staining {#sec3-1}

Brain tissue from both hemispheres in the control group was red. In contrast, damaged regions in the right hemispheres of the MCAO rats appeared white (the typical color for damage) 144 hours after MCAO. This differed significantly from the contralateral normal brain tissue. The white staining was primarily located in the frontal lobe and the anterior region of the temporal lobe, which corresponds to the location of the middle cerebral artery (**[Figure 2](#F2){ref-type="fig"}**).

![Pathological change of cerebral ischemia/reperfusion rats (2,3,5-triphenyltetrazolium chloride staining).\
The white parts of the brain tissue are the infarcts, and their locations are in the area of middle cerebral artery.](NRR-12-925-g004){#F2}

### Hematoxylin-eosin staining {#sec3-2}

Brain tissue of the control group was clear and integral. The layout of the neurons was dense and regular and plenty of cytoplasm was lightly stained. The nuclei were located in the middle, and the nucleoli were clear. Glial cells were integral, and arranged densely, with distinct nucleoli. There was no red staining in cytoplasm. The intercellular substance was compact, and no edema could be seen. In contrast, microstructural changes in the infarct area were observed at 144 hours after MCAO. In these brains, staining was shallow in the center of the infarct area. We observed fewer cells, shrunken nuclei, and smaller nucleoli. Cell shape was irregular, with interstitial edema and endothelial swelling. Large numbers of central vacuoles could be seen as well as increased number of inflammatory cells at the site of injury (**[Figure 3](#F3){ref-type="fig"}**).

![Pathological changes in the frontal lobe and the front of the temporal lobe in rat models of cerebral ischemia/reperfusion injury (hematoxylin-eosin staining, × 200).\
(A--D) The white regions indicate lesions, and were primarily located in the frontal cortex and the anterior temporal cortex. This corresponded to the region of the middle cerebral artery. Staining was weak in the center of the infarct area, with fewer cells, shrunken nuclei, and smaller nucleoli. Cell shape was irregular, with interstitial edema and endothelial swelling. Large numbers of central vacuoles could be seen, and the number of inflammatory cells at the injury site was high. Yellow arrows point to vacuoles. Green arrows point to pyknosis. Black arrows point to lighter color.](NRR-12-925-g005){#F3}

Thus, the model rats were successfully established using the modified thread-occlusion method. Cerebral infarctions and their locations (middle cerebral artery region) were confirmed through observing neurological impairment, TTC staining, and hematoxylin-eosin staining.

Effects of EA on ACTH and Hsp70 levels in serum of MCAO rats {#sec2-11}
------------------------------------------------------------

After cerebral ischemia/reperfusion injury, ACTH expression levels in the MCAO group had two typical peaks. The first was at 12 hours and the second was at 48 hours after injury. Compared with the control group, ACTH levels in the MCAO group were markedly higher at 12, 48, and 144 hours (*P* \< 0.05). Compared with the control group, ACTH levels in the EA group were significantly lower at 12, 48, 72, and 144 hours (*P* \< 0.01 or *P* \< 0.05; **[Figure 4A](#F4){ref-type="fig"}**).

![Effect of EA on ACTH (A) and Hsp70 levels (B) in serum of cerebral ischemia/reperfusion rats.\
Data are expressed as the mean ± SD (*n* = 10 rats in each group at each time point). Normally distributed data with equal variance were compared with one-way analysis of variance. Normally distributed data with unequal variances were compared with an approximate *F* test. Non-normally distributed data were compared with a non-parametric test. \**P* \< 0.05, *vs*. control group; \#*P* \< 0.05, \#\#*P* \< 0.01, *vs*. MCAO group. EA: Electroacupuncture; MCAO: middle cerebral artery occlusion; ACTH: adrenocorticotrophic hormone; Hsp70: heat shock protein 70.](NRR-12-925-g006){#F4}

The secretion of Hsp70 was limited in the normal rats. After cerebral ischemia/reperfusion injury, its expression in the MCAO group had two typical peaks. The first was at 24 hours and the second was at 72 hours. Compared with the control group, Hsp70 levels in the MCAO group were significantly greater at 12, 24, 48, 72, 96, and 144 hours (*P* \< 0.01). Compared with the MCAO group, Hsp70 levels in the EA group were significantly lower at 12 hours (*P* \< 0.05; **[Figure 4B](#F4){ref-type="fig"}**).

Discussion {#sec1-4}
==========

The pathological and physiological mechanism underlying cerebral ischemia/reperfusion injury is now thought to be associated with an injury cascade that includes several sub-mechanisms, such as excitatory toxicity (Lewerenz and Maher, 2015), peripheral depolarization, inflammation (Cuenca-López et al., 2010; Mozaffarian et al., 2015), lipid peroxide reaction caused by oxidative stress (Ying and Xiong, 2010), and programmed cell death. The relationship between these processes is mutually cause-and-effect. After the central nervous system is damaged, the sympathetic nervous system and the hypothalamus-pituitary-adrenal axis can be activated by neurotransmitters. This activates the stress response to systemic injury, and inflammatory mediators and chemokines are released to accelerate inflammation. The release of adhesion molecules produces the inflammatory mediators, causes secondary brain injury after ischemia, and starts the repairing process, thus playing a role in protecting the brain (Taupin, 2008; Denes et al., 2010). An increasing number of studies have shown that the main cause of cerebral ischemia/reperfusion injury is inflammation, which can be thought of as a secondary injury after the initial ischemia (Worthmann et al., 2015; Xu et al., 2016). The activation and aggregation of various cells play indispensable roles in receiving and transmitting the inflammatory signal. These cells include immune cells, mononuclear cells, macrophages, granulocytes, different subtypes of T cells, glial cells, and especially microglia. Adhesion molecules include selectin, immunoglobulin superfamily, integrin and inflammatory mediators, which are highly expressed and participate in the inflammatory response after ischemic injury (Jordan et al., 2008). Studies have shown that inhibiting inflammation after ischemic injury might be a new strategy for the treatment of ischemic stroke (Jin et al., 2010; Yoo et al., 2016).

Studies have found that acupuncture treatment reduces ischemia/reperfusion injury through multiple paths and targets (Feng et al., 2013; Liu et al., 2015a; Jin et al., 2016), and that it has multiple functions such as reducing inflammation, neuron protection, and promoting the repair of damaged neurons (Yang et al., 2012). EA treatment at *Baihui* and *Renzhong* (DU26) can reduce microglial activation after ischemia/reperfusion in rats. Brain-resuscitation acupuncture can inhibit the production and expression of inflammatory factors that affect rat models of focal cerebral ischemia. Acupuncture at *Zusanli* can affect the functions of lymphocytes and mononuclear macrophages, and reduce the expression of tumor necrosis factor. EA at *Quchi* (LI11) and *Zusanli* in rat models of ischemia/reperfusion can adjust the secretion levels of inflammatory inhibitors through Toll-like receptor 4/nuclear factor-κB signaling pathway, which improves defective nervous function and reduces the infarct size (Wang et al., 2008; Cheng et al., 2011; Lan et al., 2013).

From the point of view of traditional Chinese medicine, the essential pathogeny of stroke is deficiency of *qi* and blood, the imbalance of *Yin* and *Yang*. Chaos of *qi* and blood leads to the paralysis and hemorrhage of the vein, and brings about pathogenic factors that invade the brain. All of these are due largely to a lifestyle that includes worry, anger, weariness, internal injuries, and eating fatty foods. The location of the disease is in the brain, and strongly associated with the heart, liver, spleen and kidney. The nature of disease is asthenia in origin and asthenia in superficiality. Acupuncture has the function of regulating channels, harmonizing *qi* and blood, and strengthening body resistance to dispel pathogenic factors. According to the meridian theory of traditional Chinese medicine, the *Baihui* acupoint is located in the brain, and is an important point related to the *Du* meridian. The *Baihui* acupoint has the following functions: consciousness-restoration, regulating *qi* and treating the spirit, and recuperating depleted *yang* to treat collapse; it is the proximal acupoint. According to the theory that recommends "treating flaccidity and selecting only the *Yangming* meridian", which can be seen in Plain Questions (Su Wen), we know that the *Yangming* meridian is a channel with plenty of *qi* and blood, and that *Zusanli* is the *he*-sea point for the stomach channel of the foot *Yangming*. Acupuncture at *Zusanli* can treat consumption, and is a critical acupoint related to health care. *Zusanli* can regulate *qi* and blood, act as a tonic to build up healthful vital energy, and is a distal acupoint. Therapeutic effects can be improved with the proximal and distal acupoints, and this is also the characteristic therapy in traditional Chinese medicine.

From our experiment, we found low levels of ACTH and Hsp70 expression in the peripheral blood of normal rats. After the stress response was triggered, their expression levels exhibited bimodal trends. After intervention with EA, the expression of ACTH decreased, reached a peak at 24 hours, and then was maintained at low levels of expression. Hsp70 expression in peripheral blood was significantly lower at the first peak, and maintained a slow level after the first peak. After measuring changes at six time points, we can conclude that the best recovery after cerebral ischemia/reperfusion injury occurs when EA is administered within 24 hours. The results indicate that cerebral ischemia/reperfusion injury has a critical time-window for effective treatment with EA. This evidence indicates that cerebral ischemia/reperfusion injury can be relieved by EA by suppressing excessive stress responses, reducing inflammatory injury, promoting the contact between cells, and starting the repair process. This curative effect depending on the timing of the EA. Studying more time points and signals in future experiments will hopefully positively influence clinical treatment.
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